Divis Laboratories Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Quarterly Results    (DIVI)

Here are the latest quarterly results of Divis Laboratories. For more details, see the Divis Laboratories financial fact sheet and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Divis Laboratories Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m14,45613,96313,89717,30517,49317,01417,88219,606 
Other income Rs m470417767173136193235360 
Turnover Rs m14,92614,37914,66417,47817,62917,20818,11719,966 
Expenses Rs m9,5509,0249,45310,30410,08210,10210,71911,086 
Gross profit Rs m4,9064,9394,4457,0017,4116,9127,1638,521 
Depreciation Rs m459467498562611682701733 
Interest Rs m3816422323 
Profit before tax Rs m4,8794,8734,7106,6106,9356,4216,6958,145 
Tax Rs m1,3111,2828271,6891,7391,7151,6752,574 
Profit after tax Rs m3,5683,5913,8824,9215,1964,7065,0205,571 
Gross profit margin %33.935.432.040.542.440.640.143.5 
Effective tax rate %26.926.317.625.625.126.725.031.6 
Net profit margin %24.725.727.928.429.727.728.128.4 
Diluted EPS Rs 13.4 13.5 14.6 18.5 19.6 17.7 18.9 21.0  
Diluted EPS (TTM) Rs NA NA 51.9 60.1 66.3 70.5 74.7 77.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: Divis Laboratories 1QFY22 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   GODAVARI DRU  DR LALCHANDANI LABS  ALPA LAB  JUBILANT INDUSTRIES  DISHMAN PHARMA  

Compare DIVIS LABORATORIES With:   GODAVARI DRU  DR LALCHANDANI LABS  ALPA LAB  JUBILANT INDUSTRIES  DISHMAN PHARMA  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Oct 14, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS